Evoke Pharma (NASDAQ:EVOK) Stock Price Passes Below 200-Day Moving Average of $0.90

Evoke Pharma, Inc. (NASDAQ:EVOK)’s share price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.90 and traded as low as $0.43. Evoke Pharma shares last traded at $0.44, with a volume of 15,641 shares changing hands.

Wall Street Analyst Weigh In

Separately, StockNews.com assumed coverage on Evoke Pharma in a research report on Friday. They issued a “sell” rating for the company.

Evoke Pharma Stock Down 2.6 %

The firm has a market capitalization of $3.70 million, a PE ratio of -0.19 and a beta of 0.22. The stock has a 50-day moving average price of $0.60 and a 200 day moving average price of $0.90.

Evoke Pharma (NASDAQ:EVOK) last issued its quarterly earnings results on Thursday, March 14th. The specialty pharmaceutical company reported ($0.59) earnings per share for the quarter. The company had revenue of $1.68 million during the quarter. Evoke Pharma had a negative net margin of 150.43% and a negative return on equity of 517.99%.

Evoke Pharma Company Profile

Evoke Pharma, Inc, a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults.